Strategic Planning for the Biotechnology Enterprise

4 Credits.

Strategic Planning for the Biotechnology Enterprise is an overview of strategy, Life Sciences product research and development planning, regulatory pathways and tactical business execution. It focuses on creating value through strategy formulation and market implementation. Topics covered include venture investments, acquisitions and integrations, leadership and technology competencies, intellectual property, regulatory strategy, competitive differentiation, and clinical and financial value creation. Best practices in strategic planning are explored through real life published case studies of companies such as Genentech / Roche, Gilead, Alnylam, Moderna and Tempus AI. The class will also evaluate the impact and implications of policy, such as the Inflation Reduction Act, and technology, such as artificial intelligence and machine learning, on current and future initiatives of biotechnology ventures.